Article
FcR may function as a progression factor of nonlymphoid tumors.
Immunologic research - 1 Jan 1992
Witz I P, Ran M
Abstract excerpt
Tumor progression is a multistep process involving genetic and epigenetic changes in a transformed clone. Some of these changes may be induced by host factors which may also select for transformed cellular variants with a high ability to survive and propagate. In this article we review studies showing that receptors for the Fc portion of IgG may be expressed on cells from human or animal tumors of nonlymphoid...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
